Literature DB >> 26431507

Genetic Predisposition to Polycystic Ovary Syndrome, Postpartum Weight Reduction, and Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes.

Tiange Wang1, Junhong Leng1, Nan Li1, Aline Martins de Carvalho1, Tao Huang1, Yan Zheng1, Weiqin Li1, Huikun Liu1, Leishen Wang1, Gang Hu1, Lu Qi1.   

Abstract

CONTEXT: Polycystic ovary syndrome (PCOS) is a common condition in reproductive-aged women and a major female-specific risk factor of obesity, impaired glucose tolerance, and diabetes.
OBJECTIVE: We examined whether the genetic variation predisposing to PCOS affected glycemic changes in women with prior gestational diabetes mellitus (GDM) and whether such an effect was modified by changes in body adiposity, especially during and after pregnancy. DESIGN, SETTING, AND PARTICIPANTS: This is a longitudinal study in Tianjin, China. We genotyped 7 genome-wide association study-identified PCOS single nucleotide polymorphisms and assessed gestational weight gain and changes in glycemic traits and weight at 1 to 5 years postpartum in 1133 women with prior GDM. MAIN OUTCOME MEASURES: The main outcome measure was postpartum glycemic changes.
RESULTS: The PCOS genetic risk score significantly interacted with postpartum weight reduction on changes in fasting glucose and 2-h glucose (P for interaction = .032 and .007; respectively) after multivariable adjustment. In women with postpartum weight reduction of ≥ 5 kg/y, the genetic risk score was associated with decreased fasting and 2-h glucose, whereas an opposite genetic effect was found in women who lost less weight. The association between postpartum weight reduction and glycemic improvement was more significant among women with a higher genetic risk score.
CONCLUSIONS: In a large cohort of Chinese women with a history of GDM, our data for the first time indicate that the genetic predisposition to PCOS may interact with postpartum weight reduction on long-term glycemic changes, emphasizing the importance of postpartum weight management in prevention of diabetes in this subgroup of women.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26431507      PMCID: PMC4667164          DOI: 10.1210/jc.2015-2664

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study.

Authors:  Joan C Lo; Seth L Feigenbaum; Gabriel J Escobar; Jingrong Yang; Yvonne M Crites; Assiamira Ferrara
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

2.  [Comparison of assessment of food intakes by using 3 dietary survey methods].

Authors:  Yan-ping Li; Yu-na He; Feng-ying Zhai; Xiao-guang Yang; Xiao-qi Hu; Wen-hua Zhao; Guan-sheng Ma
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2006-07

3.  Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome.

Authors:  R J Norman; L Masters; C R Milner; J X Wang; M J Davies
Journal:  Hum Reprod       Date:  2001-09       Impact factor: 6.918

Review 4.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Lisa J Moran; Marie L Misso; Robert A Wild; Robert J Norman
Journal:  Hum Reprod Update       Date:  2010-02-16       Impact factor: 15.610

5.  Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults--study on optimal cut-off points of body mass index and waist circumference in Chinese adults.

Authors:  Bei-Fan Zhou
Journal:  Biomed Environ Sci       Date:  2002-03       Impact factor: 3.118

6.  Pregnancy outcome in women with PCOS and in controls matched by age and weight.

Authors:  L Haakova; D Cibula; K Rezabek; M Hill; M Fanta; J Zivny
Journal:  Hum Reprod       Date:  2003-07       Impact factor: 6.918

7.  Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome.

Authors:  A Dunaif; K R Segal; D R Shelley; G Green; A Dobrjansky; T Licholai
Journal:  Diabetes       Date:  1992-10       Impact factor: 9.461

8.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome.

Authors: 
Journal:  Fertil Steril       Date:  2004-01       Impact factor: 7.329

9.  Physical activity level and its association with metabolic syndrome among an employed population in China.

Authors:  G Ma; D Luan; Y Li; A Liu; X Hu; Z Cui; F Zhai; X Yang
Journal:  Obes Rev       Date:  2008-03       Impact factor: 9.213

10.  Risk of T2DM and impaired fasting glucose among PCOS subjects: results of an 8-year follow-up.

Authors:  Monique Y Boudreaux; Evelyn O Talbott; Kevin E Kip; Maria M Brooks; Selma F Witchel
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

View more
  2 in total

1.  Could perturbed fetal development of the ovary contribute to the development of polycystic ovary syndrome in later life?

Authors:  Monica D Hartanti; Roseanne Rosario; Katja Hummitzsch; Nicole A Bastian; Nicholas Hatzirodos; Wendy M Bonner; Rosemary A Bayne; Helen F Irving-Rodgers; Richard A Anderson; Raymond J Rodgers
Journal:  PLoS One       Date:  2020-02-20       Impact factor: 3.240

2.  Zinc-Associated Variant in SLC30A8 Gene Interacts With Gestational Weight Gain on Postpartum Glycemic Changes: A Longitudinal Study in Women With Prior Gestational Diabetes Mellitus.

Authors:  Tiange Wang; Huikun Liu; Leishen Wang; Tao Huang; Weiqin Li; Yan Zheng; Yoriko Heianza; Dianjianyi Sun; Junhong Leng; Shuang Zhang; Nan Li; Gang Hu; Lu Qi
Journal:  Diabetes       Date:  2016-09-06       Impact factor: 9.461

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.